LICENSE, DEVELOPMENT AND SUPPLY AGREEMENT BETWEEN McNEIL PDI Inc. (acting through its McNEIL Consumer Healthcare Division) a corporation existing under the laws of Canada AND McNEIL Consumer & Specialty Pharmaceuticals Division of McNEIL-PPC, Inc. a...License, Development and Supply Agreement • October 21st, 2004 • Imi International Medical Innovations Inc • Services-medical laboratories • New York
Contract Type FiledOctober 21st, 2004 Company Industry Jurisdictionamount of Net Sales during such Fiscal Quarter and a calculation of the royalties due and such other information as called for in the format attached as Appendix L. McNEIL shall deliver the written report for each such Fiscal Quarter, regardless of whether when any royalties are required to be paid in that Fiscal Quarter, commencing in the first Fiscal Quarter following the date of the First Commercial Sale of any Product. Each such report shall state, separately for McNEIL and each Sublicensee, the number, description, and aggregate Net Sales, by country, of each Product sold during the Fiscal Quarter upon which a royalty is payable under this Agreement.
LICENSE, DEVELOPMENT AND SUPPLY AGREEMENT BETWEEN McNEIL PDI Inc. (acting through its McNEIL Consumer Healthcare Division) a corporation existing under the laws of Canada AND McNEIL Consumer & Specialty Pharmaceuticals Division of McNEIL-PPC, Inc. a...License, Development and Supply Agreement • June 9th, 2004 • Imi International Medical Innovations Inc • Services-medical laboratories • New York
Contract Type FiledJune 9th, 2004 Company Industry JurisdictionFor example, if in a given Calendar Year in the Territory, the Net Sales for Licensed Products sold by McNEIL in the Territory were: ***** for Net Sales in the U.S. and ***** for Net Sales in Japan, then the royalty owed to IMI by McNEIL for that Calendar Year would be the sum of *****.